Hypomethylating agent induction therapy followed by hematopoietic cell transplantation is feasible in patients with myelodysplastic syndromes.
Year: 2010
Type: article
Study design: Observational Study
Source: PubMed
Institutions: University of Florida Health, University of Florida
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1548279023
